Table 1. Inclusion criteria of the HONEST Study.

1) Olmesartan (OLM)-naive patients with essential hypertension.

2) Ambulatory outpatients who were able to visit the clinic unassisted.

3) Patients from whom written informed consent was obtained.

4) Patients whose blood pressure (BP) levels were measured in physician‘s office at least once within 28 days before starting OLM administration.

5) Patients whose morning BP levels were measured by arm-cuff BP monitor at home at least twice on different days within 28 days before administration of OLM.